PharmAthene (PIP) to Issue Update on SparVax(TM) Contract Modification Suspension

March 22, 2010 8:34 AM EDT Send to a Friend
PharmAthene, Inc. (NYSE Amex: PIP) announced today that in addition to its year end results, it will provide an update ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login